Contact

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

99 100 Next >

Firmoo Announces Biggest Black Friday & Cyber Monday Deals – The Perfect Holiday Gift For Friends & Family

November 19, 2025

Via AB Newswire

Why Shares in Agios Pharmaceuticals Got Crushed Today ↗

November 19, 2025

Via The Motley Fool

Merck's Investigational Two-Drug Regime Matches Gilead's Three-Drug Tablet For HIV Treatment ↗

November 19, 2025

Via Benzinga

QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm

November 19, 2025

Via NewMediaWire

QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm

November 19, 2025

Via TheNewswire.com

John B. Sanfilippo & Son (NASDAQ: JBSS) Pivots to Consumer-Centric Growth, Reshaping the Snack Landscape

November 19, 2025

Via MarketMinute

FAXVIN Unveils Enhanced CarRank, a 0-100 Single-Score Summary That Makes Used-Car Decisions Faster

November 19, 2025

Via AB Newswire

Targeted Cancer Therapies Gain Momentum as Precision Market Surges Past $106B

November 19, 2025

Via FinancialNewsMedia

When it comes to breast cancer, knowing your HER2 status matters

November 19, 2025

Via Brandpoint

Levi & Korsinsky Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ATYR

November 19, 2025

Via NewMediaWire

Levi & Korsinsky Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ATYR

November 19, 2025

Via TheNewswire.com

Eternal Holdings Announces Premiere of The Impossible Dream, the First Fully AI-Created, Rock Opera Two-hour feature, over 40 original songs, and a new model for how movies can be made

November 19, 2025

Via Press Release Distribution Service

Tonix Pharmaceuticals Stock Jumps Into Retail Spotlight After $25M Buyback Boost — Traders See ‘Blueprint For Rerating’ ↗

November 18, 2025

Via Stocktwits

Pact & Partners Announces Specialized Executive Search Services for Foreign Biotech and Pharma Companies Entering U.S. Market

November 18, 2025

Via AB Newswire

Healthcare Sector Navigates Volatile Markets: A Defensive Anchor or Driven by Innovation?

November 18, 2025

Via MarketMinute

uniQure N.V. Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm

November 18, 2025

Via NewMediaWire

uniQure N.V. Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm

November 18, 2025

Via TheNewswire.com

Where Technology Meets Care: Boolean Cloud Redefines Cleanliness for Pet-loving Homes

November 18, 2025

Via Get News

Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 3Q25

November 18, 2025

Via Newsfile

Why Big Pharma Won't Quit the Diet. Who Will Win the Next Weight Loss Battle? ↗

November 18, 2025

Via The Motley Fool

Levi & Korsinsky Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ATYR

November 18, 2025

Via NewMediaWire

Levi & Korsinsky Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ATYR

November 18, 2025

Via TheNewswire.com

Market Movers in Motion: Merck & Co. and Amer Sports Chart Volatile Courses

November 18, 2025

Via MarketMinute

FDA Clears Arrowhead Pharma's First-Ever Home Injection For Rare Fat Disorder ↗

November 18, 2025

Via Benzinga

Major Victory For Genmab As Epkinly Receives FDA Approval For Type Of Pretreated Blood Cancer ↗

November 18, 2025

Via Benzinga

Annovis Stock Rises After Company Confirms Meeting With Regulators To Discuss Drug In Treating Parkinson's Disease Dementia ↗

November 18, 2025

Via Stocktwits

InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Secures FDA Type C Meeting to Advance Parkinson’s Disease Dementia Program

November 18, 2025

Via Investor Brand Network

Ocumension Therapeutics Highlights Global Myopia Burden and Regulatory Progress in Low-Dose Atropine Therapies

November 18, 2025

Via AB Newswire

How Does Tesla Make Money? ↗

November 18, 2025

Via The Motley Fool

Envoy Medical Achieves Six-Month Milestone with First 10 Patients in Acclaim(R) Cochlear Implant Clinical Trial

November 18, 2025

Via Newsfile

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Starting at $3.75/week.

Subscribe Today